Delivery Order SPE2DP21D0002-SPE2DP22F2709

<p>The Defense Logistics Agency Troop Support Medical (DOD-DLA) awarded a $374,220.00 firm fixed price delivery order contract to the Canadian Commercial Corporation, a company owned by the Government of Canada, to provide 8509501081 Pyridostigmine Bromide. The place of performance will be 2323 Riverside Drive in Ottawa, Ontario, Canada, with work scheduled to take place between November 1, 2022 and March 1, 2023. No subcontractors were identified.</p>

The Defense Logistics Agency Troop Support Medical awarded a $368,730 firm fixed price delivery order contract to the Canadian Commercial Corporation for the procurement of 8508661026 pyridostigmine bromide. The place of performance is 2323 Riverside Drive in Ottawa, Ontario, Canada. As the parent of the awardee, the contract is ultimately being fulfilled by the Government of Canada. No set-aside provisions were applied to this contract action. The delivery order was awarded on November 3,...

The Defense Logistics Agency Troop Support Medical awarded a $368,730 firm fixed price delivery order contract to the Canadian Commercial Corporation for the procurement of 8508348591 pyridostigmine bromide. As the parent company of the awardee, the contract will ultimately be fulfilled by the Government of Canada. No set-aside provisions were applied to this award placed under an unspecified existing vehicle held by the Canadian Commercial Corporation. Performance will occur at the specified...

The U.S. Defense Logistics Agency Troop Support Medical awarded a $370,440.00 Firm Fixed Price delivery order contract to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada, to provide Pyridostigmine Bromide. This contract does not have a set-aside designation. The Canadian Commercial Corporation has previously acted as a prime contractor to the Department of Defense, providing a variety of goods and services including aviation and vehicle components,...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The contract, valued at $356,130.00, is for the delivery of pyridostigmine bromide, a pharmaceutical used for the treatment of myasthenia gravis and as a pretreatment for nerve agent...

This federal contract award is for the delivery of 4,565,440 units of pyridostigmine bromide 30 mg tablets to the Defense Logistics Agency (DLA). The $7,824.48 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024 with an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical valued up to...

The Defense Logistics Agency awarded a $23,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 boxes of 60 mg pyridostigmine bromide tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. This delivery order was issued against the DLA's Pharmaceutical Prime Vendor contract vehicle to supply this pharmaceutical product in support of the Agency's...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,016,928 units of the pharmaceutical product pyridostigmine bromide 30 mg tablets. The contract has a ceiling value of $3,848.05 and a period of performance through March 20, 2024. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The $2,017.21 firm fixed price award is for the delivery of pyridostigmine bromide 30 mg tablets, a medication used to treat myasthenia gravis. The order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...

The federal contract award described is for the procurement of 4566342092 Pyridostigmine BR 30 mg Tablets by the Defense Logistics Agency (DLA), a defense agency. The $5,845.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 5, 2024, with a completion date of November 6, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA...